drugset

drugset / Trial / NCT00586625

Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers

NCT00586625 ↗

Phase 3 Completed 861 enrolled Bausch & Lomb Incorporated

RandomizedParallel-groupDouble-blindTreatment

Summary

Safety study for bepotastine besilate ophthalmic solution in normal volunteers

Timeline

Start: 2007-10
Primary completion: 2008-05
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bepotastine	Small molecule	1.5 %	Topical

Indications